Neola Medical

16/03/2026

📣 Neola Medical Completes Enrollment in Swedish Clinical Pilot Study 👶🫁

All ten babies have now been included in the study, marking an important milestone with the first real-world use of Neola® in its target patient population in neonatal intensive care. 🌟

💡 Read more in the press release here: https://neolamedical.com/mfn_news/neola-medical-completes-enrollment-in-swedish-clinical-pilot-study/

12/02/2026

Did you miss Neola Medical’s Q4 report presentation hosted by Investor Studios?

Catch up on the highlights from Neola Medical’s year-end Q4 report for 2025. CEO Hanna Sjöström reflects on a year marked by key milestones as we entered the clinical phase, strengthened the organization, and continued to build on our most strategically important assets. CFO David Folkesson presents the financial results for Q4 2025.

🎥 Watch the report presentation and stay for the Q&A session here:

On the 12th of February at 11.00 CET, CEO Hanna Sjöström and CFO David Folkesson from Neola Medical will present the company’s earnings for the fourth quarte...

12/02/2026

📣 Neola Medical today released the Q4 report of 2025! 📘👶🏻 – Advancing IP Protection as a Core Strategic Asset across Key Markets

“This year we initiated our first clinical pilot study on preterm born babies in Sweden, representing the first real-world use of Neola® for continuous monitoring of its target patient population.”, says CEO Hanna Sjöström

💡 Read the entire press release and the report at our website: https://neolamedical.com/mfn_news/neola-medical-q4-report-2025-advancing-ip-protection-as-a-core-strategic-asset-across-key-markets/

🎥 Don’t miss when CEO Hanna Sjöström and CFO David Folkesson presents the Q4 report today at 11 am (CET). Watch the presentation here: https://youtube.com/live/-_0FXFp8uXM

06/02/2026

📢 Medtech Leaders and Clinical Expert Call for MDR Reform in Dagens industri

In a debate article published in Dagens Industri, four medtech CEOs, including Neola Medical’s CEO Hanna Sjöström, together with a professor at Lund University and senior clinician at Skåne University Hospital, highlight how the EU MDR framework is slowing innovation and driving investment away from Europe. 🇪🇺

As MDR is currently under review, the authors outline concrete steps to restore a more innovation-enabling regulatory pathway while maintaining high standards of patient safety.

💡 The debate article in Dagens industri is available to read (in Swedish) here: https://www.di.se/debatt/regelbordan-kvaver-svensk-medtech/

05/02/2026

📣 We hereby invite you to a live presentation of our Q4 report of 2025!

The Q4 report of 2025 will be presented by CEO Hanna Sjöström and CFO David Folkesson online hosted by Investor Studios. Following the presentation, there will be a Q&A, where viewers have the opportunity to ask questions directly in the live chat.

🗓️ February 12, 2026, at 11:00 CET (11.00)
🎥 Watch the presentation here: https://youtube.com/live/-_0FXFp8uXM

💡Read more in the press release here: https://neolamedical.com/mfn_news/neola-medical-invites-to-presentation-of-the-q4-report-2025/

17/12/2025

📣 Today we released the winter edition of Neola Medical’s Investor Letter 2025

“2025 has been a year of important clinical and organizational progress for Neola Medical. With a solid technological and intellectual property foundation, we continue to move forward in both our clinical development and organizational growth,” says CEO Hanna Sjöström

💡 Read the entire press release and the investor letter here: https://neolamedical.com/mfn_news/neola-medicals-ceo-shares-recent-company-highlights-in-winter-2025-investor-letter/

15/12/2025

Study visit at Stanford NICU 👶🇺🇸

Last week Neola Medical had the opportunity to visit the Neonatal Intensive Care Unit (NICU) at Stanford Medicine Children's Health in Palo Alto — widely recognized as a global reference center for neonatal care in the U.S.

We were pleased to meet with Dr. Valerie Chock and Impact1 co-director Janene Fuerch and gain valuable insights into daily clinical practice in the NICU.

A sincere thank you to the Stanford team for the warm welcome and for your extraordinary commitment to the most vulnerable patients 🌟

💡 Learn more about the NICU here: www.stanfordchildrens.org

09/12/2025

📣 Neola Medical expands leadership team with appointment of Director Disposable Product Development

“Strengthening our leadership team with experience in scaling advanced disposables is of outmost strategic importance for Neola Medical as our disposables are a key driver for future recurring revenue streams. Charlotta Lagerblad brings deep experience in taking advanced disposable products from innovation into large scale manufacturing and global sales,” says CEO Hanna Sjöström.

💡 Read more in the press release here: https://neolamedical.com/mfn_news/neola-medical-expands-leadership-team-with-appointment-of-director-disposable-product-development/

04/12/2025

🚀 Explore our new website! 🚀

We’ve launched a new version of our website to make it easier to follow our progress, learn about our technology, and access investor information. We hope you will appreciate the new design and improved navigation, developed to give shareholders and partners an even clearer overview of our journey.

“Our updated website mirrors Neola Medical’s continued progress and growing presence in both Sweden and the U.S. I invite all our shareholders and partners to visit and explore it,” says CEO Hanna Sjöström

🔗 Visit our website at www.neolamedical.com ✨

02/12/2025

📣 Neola Medical granted U.S. patent for disposable probes, strengthening future revenue model in target market 🇺🇸

“These disposables are central to our future business model, where recurring revenues from daily probe replacements are expected to provide significant leverage. Securing patent protection in the U.S. strengthens our competitive position in our most important target market and protects our unique optical design,” says CEO Hanna Sjöström

💡 Read more in the press release here: https://neolamedical.com/mfn_news/neola-medical-granted-u-s-patent-for-disposable-probes-strengthening-future-revenue-model-in-target-market/

26/11/2025

🌟 Visiting the U.S. Study Site 🇺🇸

Neola Medical recently visited the Neonatal Intensive Care Unit (NICU) at Children’s Regional Hospital at Cooper University Health Care in Camden, New Jersey — first study site for our planned clinical study on preterm born babies in the U.S. 🫁

We were grateful to meet Professor Vineet Bhandari, Principal Investigator and Division Head of Neonatology, and to receive valuable insight into the clinical environment. 🌟

A warm thank you to the Cooper team for welcoming us and for the important work you do every day for the most vulnerable patients. 👶

💡 Learn more about Children’s Regional Hospital at Cooper here: www.cooperhealth.org

13/11/2025

📣 Neola Medical granted Patent in China for reducing optical noise in lung monitoring measurements

“This Chinese patent expands our IP protection within a new patent family and strengthens our international position. The invention contributes to optimizing the Neola® system for continuous lung monitoring, helping to support consistent measurement quality,” says CEO Hanna Sjöström

About the patent
The granted patent belongs to Neola Medical’s patent family “A device for smoothing spectral transmission modulations and a method thereof” and protects the company’s innovation for optimizing measurement data by reducing interference in the optical fiber during lung monitoring.

💡 Read more in the press release here: https://www.neolamedical.com/mfn_news/neola-medical-granted-patent-in-china-for-reducing-optical-noise-in-lung-monitoring-measurements/